Opiate abuse is a chronic disorder and maintaining abstinence represents a major challenge for addicts. Individuals recovering from opiate dependence have long reported that while the acute withdrawal symptomsfrom opiates may pass relatively quickly, they do not feel quite right for several weeks or even months thereafter.
Called the protracted abstinence syndrome, this cluster of vague depressive-like symptoms can include reduced concentration, low energy level, poor sleep quality, and anhedonia. New data in animals, reported in Biological Psychiatry, now implicates the serotonin system in this phenomenon.
French researchers found that mice with chronic morphine exposure showed decreasing physical dependence during a period of abstinence, with no physical withdrawal symptoms after 4 weeks. In contrast, low sociability and despair behavior clearly developed after 4 weeks of abstinence.
Remarkably, treatment during the abstinence period with the antidepressant fluoxetine prevented the development of both social aversion and despair behavior. This is important because fluoxetine targets the serotonin system, which is known to influence mood.
Senior author Dr. Brigitte Kieffer explained that this studyestablishes a direct link between morphine abstinence and depressive-like symptoms, and strongly suggests a causal effect of serotonin dysfunction in depressive features associated with abstinence.
The greatest risk associated with protracted abstinence is relapse to drug use, comments Dr. John Krystal, Editor of Biological Psychiatry. This study provides new insights into a process that may contribute to relapse.These findings should foster novel research along serotonergic pathways in drug abuse. It is hoped that these findings can lead to real-world clinic use, since serotonergic medication is already broadly available.